Get started
ALLERGY THERAPEUTICS ORD GBP0.001ALLERGY THERAPEUTICS ORD GBP0.001ALLERGY THERAPEUTICS ORD GBP0.001

ALLERGY THERAPEUTICS ORD GBP0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

AGY chart


Full chart

AGY upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪297.90 M‬ GBP
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.02 GBP
Net income (FY)
‪−40.22 M‬ GBP
Revenue (FY)
‪55.20 M‬ GBP
Shares float
‪181.40 M‬
Beta (1Y)
0.00

Employees


Employees (FY)
612
Change (1Y)
0
Revenue / Employee (1Y)
‪90.19 K‬ GBP
Net income / Employee (1Y)
‪−65.71 K‬ GBP

About ALLERGY THERAPEUTICS ORD GBP0.001


Sector
Health Technology
CEO
Manuel Llobet
Headquarters
Worthing
Website
allergytherapeutics.com
Founded
2004
ISIN
GB00B02LCQ05
FIGI
BBG000F797G5
Allergy Therapeutics Plc is a biotechnology company, which engages in the Research and Development of allergy treatments. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AGY news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AGY is 6.26 GBX — it has decreased by −0.79% in the past 24 hours. Watch ALLERGY THERAPEUTICS ORD GBP0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ALLERGY THERAPEUTICS ORD GBP0.001 stocks are traded under the ticker AGY.
AGY stock has fallen by −3.85% compared to the previous week, the month change is a 17.92% rise, over the last year ALLERGY THERAPEUTICS ORD GBP0.001 has showed a 228.95% increase.
We've gathered analysts' opinions on ALLERGY THERAPEUTICS ORD GBP0.001 future price: according to them, AGY price has a max estimate of 13.00 GBX and a min estimate of 13.00 GBX. Watch AGY chart and read a more detailed ALLERGY THERAPEUTICS ORD GBP0.001 stock forecast: see what analysts think of ALLERGY THERAPEUTICS ORD GBP0.001 and suggest that you do with its stocks.
AGY reached its all-time high on Feb 5, 2007 with the price of 67.20 GBX, and its all-time low was 0.36 GBX and was reached on Jun 22, 2023. View more price dynamics on AGY chart.
See other stocks reaching their highest and lowest prices.
AGY stock is 8.33% volatile and has beta coefficient of 0.00. Track ALLERGY THERAPEUTICS ORD GBP0.001 stock price on the chart and check out the list of the most volatile stocks — is ALLERGY THERAPEUTICS ORD GBP0.001 there?
Today ALLERGY THERAPEUTICS ORD GBP0.001 has the market capitalization of ‪297.90 M‬, it has decreased by −1.56% over the last week.
Yes, you can track ALLERGY THERAPEUTICS ORD GBP0.001 financials in yearly and quarterly reports right on TradingView.
ALLERGY THERAPEUTICS ORD GBP0.001 is going to release the next earnings report on Mar 5, 2025. Keep track of upcoming events with our Earnings Calendar.
AGY net income for the last half-year is ‪−24.57 M‬ GBP, while the previous report showed ‪−15.65 M‬ GBP of net income which accounts for −56.95% change. Track more ALLERGY THERAPEUTICS ORD GBP0.001 financial stats to get the full picture.
No, AGY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 612.00 employees. See our rating of the largest employees — is ALLERGY THERAPEUTICS ORD GBP0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALLERGY THERAPEUTICS ORD GBP0.001 EBITDA is ‪−31.23 M‬ GBP, and current EBITDA margin is −56.93%. See more stats in ALLERGY THERAPEUTICS ORD GBP0.001 financial statements.
Like other stocks, AGY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLERGY THERAPEUTICS ORD GBP0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALLERGY THERAPEUTICS ORD GBP0.001 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALLERGY THERAPEUTICS ORD GBP0.001 stock shows the buy signal. See more of ALLERGY THERAPEUTICS ORD GBP0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.